Modulation of dopamine receptors by thyrotropin-releasing hormone in the rat brain

Nanomolar concentration of thyrotropin-releasing hormone (TRH) in vitro caused a significant reduction of [ 3H]apomorphine binding sites (70% of the control) in the rat striatum and the limbic forebrain. [ 3H]Spiperone binding was not affected by TRH. On the other hand, dopamine and apomorphine disp...

Full description

Saved in:
Bibliographic Details
Published inPeptides (New York, N.Y. : 1980) Vol. 8; no. 2; pp. 319 - 325
Main Authors Funatsu, Kunihiko S., Inanaga, Kazutoyo
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 01.03.1987
Elsevier Science
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Nanomolar concentration of thyrotropin-releasing hormone (TRH) in vitro caused a significant reduction of [ 3H]apomorphine binding sites (70% of the control) in the rat striatum and the limbic forebrain. [ 3H]Spiperone binding was not affected by TRH. On the other hand, dopamine and apomorphine displaced [ 3H]TRH binding partially, suggesting the presence of a TRH receptor subpopulation that has a high affinity for dopamine agonist. Most of the neuroleptics displaced [ 3H]TRH binding dose-dependently in the micromolar range. (−)-Sulpiride had no affinity to TRH receptors. These findings suggest that one of the important roles of TRH as a neuromodulator is to modulate receptors for classical neurotransmitters, and this receptor-receptor interaction may be of importance in explaining the well known stimulating effects of TRH on the dopaminergic system.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0196-9781
1873-5169
DOI:10.1016/0196-9781(87)90107-0